In vitro antioxidant effect of Ginkgo biloba extract (EGb 761) on lipoperoxidation induced by hydrogen peroxide in erythrocytes of Behcet's patients

Japanese Journal of Pharmacology

Volumn 75, Issue 3, 1997, Pages 253-258

  Köse, Kader ^a   Doǧan, Pakize ^a   Aşçioǧlu, Meral ^a   Aşçioǧlu, Özcan ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Behcet's disease; Erythrocyte; Ginkgo biloba extract (EGb 761); Lipid peroxidation; Malondialdehyde

Indexed keywords

GINKGO BILOBA EXTRACT; HYDROGEN PEROXIDE; LIPID; MALONALDEHYDE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE;

GINKGO BILOBA;

EID: 2642668488     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.75.253     Document Type: Article

References (38)

1. Behçet H: Über rezidiverende aphthöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105, 1152-1157 (1937) (in German)
2. Chajek T and Fainaru ML: Behçet's disease: Report of 41 cases and a review of the literature. Medicine (Baltimore) 54, 179-196 (1975)
3. Jorizzo JL, Solomon AR and Cavallo T: Behçet's syndrome. Arch Pathol Lab Med 109, 747-751 (1985)
4. O'Duffy JD: Behçet's syndrome. N Engl J Med 322, 326-327 (1990)
5. Zouboulis ChC: Morbus Adamantiandes - Behçet: Nekrotisierende System Vaskulitis mit letalem Ausgang. Hautarzt 42, 451 -545 (1991) (in German)
6. O'duffy JD: Behçet's syndrome. In Current Therapy in Dermatology, Edited by Provost TT and Farmer ER, pp 97-101, BC Decker Co, Philadelphia (1985)
7. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M and Inaba G: Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet i, 1093-1096 (1989)
8. Fierlbeck G: Morbus Behçet: Therapie mit rekombinantem Interferon-gamma. Dtsch Med Wochenschr 114, 1769 (1989) (in German)
9. Yazici H, Pazarh H, Barnes CG, Tüzün Y, Özyazgan Y, Silman A, Serdaroǧlu S, Oǧuz V, Yurdakul S, Lovatt G, Yazici B, Somani S and Müftüoǧlu A: A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 322, 281-285 (1990)
10. Niwa Y, Miyake S and Sakane T: Auto-oxidative damage in Behçet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49, 247-255 (1982)
11. Pronai L, Ichikawa Y, Nakazawa H and Arimori S: Enhanced superoxide scavenging activity of peripheral blood leucocytes in Behçet's disease - effects of colchicine. Clin Exp Rheumatol 9, 227-233 (1991)
12. Defeudis FV: Ginkgo Biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications, pp 1-8, 25-94, Elsevier Science Publishing Co, Paris (1991)
13. Köse K and Dogan P: Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 1. Protective effect of Ginkgo biloba extract (EGb 761). J Int Med Res 23, 1-8 (1995)
14. Köse K and Dogan P: Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 2. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidans. J Int Med Res 23, 9-18 (1995)
15. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 335, 1078-1080 (1990)
16. Jain SK: Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 937, 205-210 (1988)
17. Stocks J and Dormandy TL: The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol 20, 95-111 (1971)
18. Dawson-Saunders B and Trapp RG: Basic and Clinical Biostatistics. pp 101-103, 124-141, Appleton and Lange, Connecticut (1990)
19. James DW, Walker JR and Smith JD: Abnormal polymorphonuclear leucocyte chemotaxis in Behçet's syndrome. Ann Rheum Dis 38, 219-221 (1979)
20. Fujita Y, Yamada M, Asai K and Mimura Y: Generation of superoxide radical by neutrophils in Behçet's disease. Jpn J Ophthalmol 3, 221-226 (1984)
21. Pronai K, Ichikawa Y, Nakazawa H and Arimori S: Superoxide scavenging activity of leucocytes in rheumatoid arthritis and Behçet's disease. Tokai J Exp Clin Med 15, 93-97 (1990)
22. Pronai L and Arimori S: BD-104 enhances the decreased plasma superoxide scavenging activity in patients with Behçet's disease, Sjogren's syndrome or hematological malignancy. Biotherapy 3, 365-371 (1991)
23. Dogan P, Tanrikulu G, Soyuer Ü and Köse K: Oxidative enzymes of polymorphonuclear leucocytes and plasma fibrinogen, ceruloplasmin, and copper levels in Behçet's disease. Clin Biochem 27, 413-418 (1994)
24. Köse K, Doǧan P, Aşçioǧlu M, Erkiliç K and Aşçioǧlu Ö: Oxidative stress and antioxidant defences in plasma of patients with Behçet's Disease. Tohoku J Exp Med 176, 239-248 (1995)
25. Cross CE, Halliwell B, Barish ET, Pryor WA, Ames BN, Saul RL, McCord JM and Harman D: Oxigen radicals and human disease. Ann Intern Med 107, 526-545 (1987)
26. Stocks J, Offerman EL, Modell CB and Dormandy TL: The susceptibility of antioxidation of human red cell lipids in health and disease. Br J Haematol 23, 713-720 (1972)
27. Clemens MR and Waller HD: Lipid peroxidation in erythrocytes. Chem Phys Lipids 45, 251-268 (1987)
28. Wisterbourn CC and Stern A: Human red cells scavenge extracellular hydrogen peroxide and inhibit formation of hypochlorous acid and hydroxyl radical. J Clin Invest 80, 1486-1491 (1987)
29. 2 pool generated by human neutrophils. J Biol Chem 259, 399-405 (1984)
30. Mizushima Y, Hoshi K, Yanagawa A and Takaro K: Topical application of superoxide dismutase cream. Drugs Exp Clin Res XVII, 127-131 (1991)
31. Pronai L, Arimori S and Nakazawa H: Superoxide scavenging activity of BG-104 before and after sonication-determined by ESR spin trapping method. Biotherapy 2, 63-68 (1990)
32. Kleijnen J and Knipschild P: Ginkgo biloba. Lancet 340, 1136-1139 (1992)
33. Sticher O: Quality of ginkgo preparations. Plant Med 59, 2-10 (1993)
34. Barth SA, Inselmann G, Engemann R and Heidermann HT: Influences of Ginkgo biloba on cyclosporin A-induced lipid peroxidation in human liver microsomes in comparison to vitamin E, glutathione and N-acetyl-cysteine. Biochem Pharmacol 41, 1521-1526 (1991)
35. Pincemail J, Thirion A, Dupuis M, Braquet P, Driev K and Deby C: Ginkgo biloba extract inhibits oxygen species production generated by phorbol myristate acetate stimulated human leukocytes. Experientia 43, 181-184 (1987)
36. Robak J and Gryglewski RJ: Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 37, 837-841 (1988)
37. Pincemail J, Dupuis M, Nasr C, Hans P, Haag-Berrurier M, Anton R and Deby C: Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia 45, 708-712 (1989)
38. Diwok M, Kuklinski B and Erns B: Superoxide dismutase activity of Ginkgo biloba extract. Z Gesamte Inn Med 17, 308-311 (1992)